Table 1.
General characteristics of COVID-19 patients and control group.
| Variables | Patients (n=44) | Healthy controls (n=20) | p |
|---|---|---|---|
| Age, y | 63.0 (51.5-70.5) | 57.0 (51.5-63.0) | 0.087 |
| Gender, male | 32 (72.7%) | 9 (45.0%) | 0.032* |
| BMI, kg/m2 | 29.7 (27.7-33.9) | 26.0 (24.2-30.7) | 0.010* |
| SpO2, % | 90.0 (84.5-94.0) | – | – |
| Time from onset, days | 7.0 (5.0-9.0) | – | – |
| Disease severity | |||
| Moderate, n (%) Severe, n (%) |
35 (79.5%) 9 (20.5%) |
- - |
- - |
| Comorbidities | |||
| Hypertension, n (%) Diabetes, n (%) Asthma, n (%) Dyslipidaemia, n (%) |
25 (56.8%) 7 (16.0%) 3 (6.8%) 8 (18.2%) |
4 (20.0%) 0 (0.0%) 1 (5.0%) 2 (10.0%) |
0.010* 0.059 0.937 0.403 |
| Symptoms | |||
| Fever, n (%) Cough, n (%) Dyspnoea, n (%) Fatigue, n (%) |
32 (72.7%) 28 (63.6%) 24 (54.6%) 23 (52.3%) |
- - - - |
– |
| Lung involvement in CT scan on admission, % | 40.0 (40.0-60.0) | – | – |
Data represented as number or median (IQR). BMI, body mass index; SpO2, oxygen saturation; *, statistical significance.